BioAlberta’s 2026 Policy Forum Brings Together Leaders & Innovators in the Life Sciences Sector Uncategorized
BioAlberta Celebrates Life Sciences Week and Global Biotech Week at the Annual Health and Life Sciences Showcase and Awards Gala Uncategorized
“The World Can’t Wait:” BioAlberta Highlights Alberta’s Life Sciences Achievements at BIO International in Boston June 2025 Uncategorized
Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics Uncategorized
Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster Uncategorized
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older Uncategorized
Cancer diagnostics developer Syantra said Wednesday that it has raised C$4.9 million (US$3.6 million) in a Series A-1 financing round. Uncategorized
PulseMedica Raises $12 Million CAD to Advance Eye Floater Imaging and Treatment Technology Uncategorized
Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster Uncategorized
Nanostics Prostate Cancer Screening Test, ClarityDX Prostate®, becomes accessible to men in British Columbia, Saskatchewan, and Ontario Uncategorized
SciencePak™ partners with Alexander Chemical L.P., to produce and distribute a range of chemical and life sciences products and services. Uncategorized
Discover Why Health Professionals Trust NanoSALV Catalytic from NanoTess – a Novel, Cost-Effective Canadian Wound Care Technology Uncategorized